iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionEquitable Holdings, Inc.
Latest Disclosed Ownership33,007 shares
Latest Disclosed Value $ 5,570,795
Equitable Holdings, Inc. reports 41.71% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Equitable Holdings, Inc. filed a 13F-HR form disclosing ownership of 33,007 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $5,570,795 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 23,292 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 41.71% during the quarter. The current value of the position is $4,325,567 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 33,007 9,715 41.71 5,571 41.73 0.0359
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,292 7,805 50.40 3,931 75.84 0.0269
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,487 -501 -3.13 2,236 10.53 0.0164
2025-08-15 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,988 -872 -5.17 2,023 -6.22 0.0167
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,860 127 0.76 2,156 -2.53 0.0205
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,733 4,004 31.46 2,212 19.37 0.0211
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,729 -1,018 -7.41 1,853 -1.75 0.0179
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,747 3,834 38.68 1,887 38.68 0.0199
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,913 -364 -3.54 1,360 -2.58 0.0153
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,277 -233 -2.22 1,396 8.64 0.0172
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,510 -89 -0.84 1,285 -4.46 0.0184
2023-08-15 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,599 -104 -0.97 1,346 -2.68 0.0193
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,703 378 3.66 1,382 1.99 0.0221
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,325 1,465 16.53 1,356 30.79 0.0236
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,860 346 4.06 1,036 3.39 0.0202
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,514 -45 -0.53 1,002 -10.13 0.0191
2022-05-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,559 -4,601 -34.96 1,115 -44.47 0.0182
2022-02-11 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,160 2,602 24.64 2,008 17.63 0.0316
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,558 193 1.86 1,707 0.65 0.0291
2021-08-11 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,365 -738 -6.65 1,696 1.44 0.0292
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 11,103 -2,700 -19.56 1,672 -20.04 0.0354
2021-02-09 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,803 -269 -1.91 2,091 9.76 0.0476
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 14,072 241 1.74 1,905 0.74 0.0492
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,831 1,364 10.94 1,891 40.80 0.0544
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,467 -3,200 -20.43 1,343 -28.87 0.0482
2020-05-28 2019-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 15,667 15,667 1,888 0.0552
2020-02-18 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 15,667 1,888 0.0098
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.